158 related articles for article (PubMed ID: 17342335)
1. Combinatorial prevention of carcinogenic risk in a model for familial colon cancer.
Telang N; Katdare M
Oncol Rep; 2007 Apr; 17(4):909-14. PubMed ID: 17342335
[TBL] [Abstract][Full Text] [Related]
2. Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review).
Telang N; Katdare M
Oncol Rep; 2011 May; 25(5):1195-201. PubMed ID: 21399881
[TBL] [Abstract][Full Text] [Related]
3. Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome.
Telang N; Katdare M
Oncol Rep; 2009 Apr; 21(4):1017-21. PubMed ID: 19288003
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chemopreventive agents for growth inhibition of Apc [+/-] 1638NCOL colonic epithelial cells.
Katdare M; Kopelovich L; Telang N
Int J Mol Med; 2002 Oct; 10(4):427-32. PubMed ID: 12239589
[TBL] [Abstract][Full Text] [Related]
5. Cell culture model for colon cancer prevention and therapy: an alternative approach to animal experimentation.
Telang N; Katdare M
ALTEX; 2007; 24(1):16-21. PubMed ID: 17361317
[TBL] [Abstract][Full Text] [Related]
6. Cohorts with familial disposition for colon cancers in chemoprevention trials.
Burt RW
J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
[TBL] [Abstract][Full Text] [Related]
7. Prevention of early-onset familial/hereditary colon cancer: new models and mechanistic biomarkers (review).
Telang NT; Li G; Katdare M
Int J Oncol; 2006 Jun; 28(6):1523-9. PubMed ID: 16685453
[TBL] [Abstract][Full Text] [Related]
8. Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
Katdare M; Kopelovich L; Telang N
Ann N Y Acad Sci; 2001 Dec; 952():169-74. PubMed ID: 11795437
[TBL] [Abstract][Full Text] [Related]
9. Counterpoint: From animal models to prevention of colon cancer. Criteria for proceeding from preclinical studies and choice of models for prevention studies.
Bruce WR
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):401-4. PubMed ID: 12750233
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse.
Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ
Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice.
Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV
Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589
[TBL] [Abstract][Full Text] [Related]
12. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis.
Perkins S; Verschoyle RD; Hill K; Parveen I; Threadgill MD; Sharma RA; Williams ML; Steward WP; Gescher AJ
Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):535-40. PubMed ID: 12050094
[TBL] [Abstract][Full Text] [Related]
13. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
Fenton JI; Hord NG
Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
[TBL] [Abstract][Full Text] [Related]
14. Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis.
Femia AP; Soares PV; Luceri C; Lodovici M; Giannini A; Caderni G
BMC Cancer; 2015 Sep; 15():611. PubMed ID: 26335331
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive strategy to combat colon cancer targeting the adenomatous polyposis coli tumor suppressor gene.
Gerner EW; Ignatenko NA; Lance P; Hurley LH
Ann N Y Acad Sci; 2005 Nov; 1059():97-105. PubMed ID: 16382048
[TBL] [Abstract][Full Text] [Related]
16. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
17. Detection of metabolic alterations in non-tumor gastrointestinal tissue of the Apc(Min/+) mouse by (1)H MAS NMR spectroscopy.
Backshall A; Alferez D; Teichert F; Wilson ID; Wilkinson RW; Goodlad RA; Keun HC
J Proteome Res; 2009 Mar; 8(3):1423-30. PubMed ID: 19159281
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effects of lupulone, a hop {beta}-acid, on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
Lamy V; Roussi S; Chaabi M; Gossé F; Schall N; Lobstein A; Raul F
Carcinogenesis; 2007 Jul; 28(7):1575-81. PubMed ID: 17434926
[TBL] [Abstract][Full Text] [Related]
19. Impact of adenomatous polyposis coli (APC) tumor supressor gene in human colon cancer cell lines on cell cycle arrest by apigenin.
Chung CS; Jiang Y; Cheng D; Birt DF
Mol Carcinog; 2007 Sep; 46(9):773-82. PubMed ID: 17620292
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
